Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harte Hanks (HHS) Receivables (2016 - 2025)

Harte Hanks (HHS) has disclosed Receivables for 16 consecutive years, with $37.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Receivables fell 11.91% to $37.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $37.2 million, a 11.91% decrease, with the full-year FY2024 number at $39.5 million, up 14.25% from a year prior.
  • Receivables was $37.2 million for Q3 2025 at Harte Hanks, up from $34.7 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $56.1 million in Q1 2022 to a low of $29.9 million in Q1 2025.
  • A 5-year average of $42.3 million and a median of $43.7 million in 2023 define the central range for Receivables.
  • Peak YoY movement for Receivables: rose 24.32% in 2021, then crashed 30.6% in 2024.
  • Harte Hanks' Receivables stood at $49.2 million in 2021, then fell by 18.66% to $40.0 million in 2022, then fell by 13.59% to $34.6 million in 2023, then increased by 14.25% to $39.5 million in 2024, then decreased by 5.83% to $37.2 million in 2025.
  • Per Business Quant, the three most recent readings for HHS's Receivables are $37.2 million (Q3 2025), $34.7 million (Q2 2025), and $29.9 million (Q1 2025).